NOVAVAX INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Novavax Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Novavax Inc Return On Equity for the quarter ending September 30, 2024 was 44.8 %, a 39.5% decline year-over-year.
  • Novavax Inc annual Return On Equity for 2023 was 71.6 %, a 57.8% decline from 2022.
  • Novavax Inc annual Return On Equity for 2022 was 170 %.
  • Novavax Inc annual Return On Equity for 2021 was -368 %, a 96.8% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 71.6 -98 -57.8% Jan 1, 2023 Dec 31, 2023
2022 170 +538 Jan 1, 2022 Dec 31, 2022
2021 -368 -181 -96.8% Jan 1, 2021 Dec 31, 2021
2020 -187 -262 -351% Jan 1, 2020 Dec 31, 2020
2019 74.6 -78.9 -51.4% Jan 1, 2019 Dec 31, 2019
2018 153 -125 -44.9% Jan 1, 2018 Dec 31, 2018
2017 278 +608 Jan 1, 2017 Dec 31, 2017
2016 -330 -286 -660% Jan 1, 2016 Dec 31, 2016
2015 -43.4 -8.97 -26.1% Jan 1, 2015 Dec 31, 2015
2014 -34.4 +2.28 +6.21% Jan 1, 2014 Dec 31, 2014
2013 -36.7 +7.67 +17.3% Jan 1, 2013 Dec 31, 2013
2012 -44.4 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.